BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23898609)

  • 1. [Expression and clinical significance of Muc1, p63 protein in diffuse sclerosing variant of papillary thyroid carcinoma and conventional papillary thyroid carcinoma].
    Hao Y; Jin C; Wang J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(9):457-61. PubMed ID: 23898609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse sclerosing variant of papillary thyroid carcinoma--an update of its clinicopathological features and molecular biology.
    Pillai S; Gopalan V; Smith RA; Lam AK
    Crit Rev Oncol Hematol; 2015 Apr; 94(1):64-73. PubMed ID: 25577570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof].
    He F; Li H; Li WS; Dong XH
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):393-6. PubMed ID: 19567117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
    Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapse.
    Renaud F; Gnemmi V; Devos P; Aubert S; Crépin M; Coppin L; Ramdane N; Bouchindhomme B; d'Herbomez M; Van Seuningen I; Do Cao C; Pattou F; Carnaille B; Pigny P; Wémeau JL; Leteurtre E
    Thyroid; 2014 Sep; 24(9):1375-84. PubMed ID: 25012490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sonographic characteristics of diffuse sclerosing variant of papillary thyroid carcinoma with histopathological correlation: a preliminary study.
    Li W; Wang Y; Gao L; Feng R; Lv K; Wu X; Yang X; Cai S; Wang H; Li J
    Orphanet J Rare Dis; 2024 Mar; 19(1):136. PubMed ID: 38532506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis.
    Vuong HG; Kondo T; Pham TQ; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R
    Eur J Endocrinol; 2017 Apr; 176(4):433-441. PubMed ID: 28183787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of decoy receptor 3 in diffuse sclerosing variant of papillary thyroid carcinoma: correlation with M2 macrophage differentiation and lymphatic invasion.
    Chang WC; Chen JY; Lee CH; Yang AH
    Thyroid; 2013 Jun; 23(6):720-6. PubMed ID: 23186064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker.
    Wreesmann VB; Sieczka EM; Socci ND; Hezel M; Belbin TJ; Childs G; Patel SG; Patel KN; Tallini G; Prystowsky M; Shaha AR; Kraus D; Shah JP; Rao PH; Ghossein R; Singh B
    Cancer Res; 2004 Jun; 64(11):3780-9. PubMed ID: 15172984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases.
    Regalbuto C; Malandrino P; Tumminia A; Le Moli R; Vigneri R; Pezzino V
    Thyroid; 2011 Apr; 21(4):383-9. PubMed ID: 21309722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.
    Mostoufi-Moab S; Labourier E; Sullivan L; LiVolsi V; Li Y; Xiao R; Beaudenon-Huibregtse S; Kazahaya K; Adzick NS; Baloch Z; Bauer AJ
    Thyroid; 2018 Jan; 28(1):60-67. PubMed ID: 29108474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.
    Raffaelli M; De Crea C; Sessa L; Fadda G; Lombardi CP; Bellantone R
    Endocrine; 2018 Oct; 62(1):64-70. PubMed ID: 29770933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical characteristics of diffuse sclerosing variant of papillary carcinoma: comparison with conventional papillary carcinoma.
    Koo JS; Shin E; Hong SW
    APMIS; 2010 Oct; 118(10):744-52. PubMed ID: 20854468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The study of the correlation of papillary thyroid carcinoma's invasion toward Ezrin and E-cadherin].
    Liu C; Chen X; Gao Z; Liu Z; Tao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(17):789-91, 795. PubMed ID: 23214316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Incidence of Distant Metastasis Is Associated With Histopathological Subtype of Pediatric Papillary Thyroid Cancer - a Retrospective Analysis Based on SEER.
    Zeng X; Wang Z; Gui Z; Xiang J; Cao M; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Zhang T; Shao L; Zhang P; Zhang H
    Front Endocrinol (Lausanne); 2021; 12():760901. PubMed ID: 34858334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma.
    Baek SK; Woo JS; Kwon SY; Lee SH; Chae YS; Jung KY
    Laryngoscope; 2007 May; 117(5):911-6. PubMed ID: 17473695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of metadherin correlates with malignant pathological features and poor prognostic significance in papillary thyroid carcinoma.
    Li WF; Wang G; Zhao ZB; Liu CA
    Clin Endocrinol (Oxf); 2015 Oct; 83(4):572-80. PubMed ID: 25418110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid.
    Bièche I; Ruffet E; Zweibaum A; Vildé F; Lidereau R; Franc B
    Thyroid; 1997 Oct; 7(5):725-31. PubMed ID: 9349575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma.
    Okuyucu K; Alagoz E; Arslan N; Emer O; Ince S; Deveci S; Ayan A; Taslipinar A; Gunalp B; Azal O
    Nucl Med Commun; 2015 Oct; 36(10):1021-5. PubMed ID: 26225942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis.
    Kim HS; Lee JJ; Do SI; Kim K; Do IG; Kim DH; Chae SW; Sohn JH
    Int J Clin Exp Pathol; 2015; 8(5):5695-701. PubMed ID: 26191283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.